Intrinsic Value of S&P & Nasdaq Contact Us

Mereo BioPharma Group plc MREO

NASDAQ Global Market

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$0.83
+153.3%

Mereo BioPharma Group plc (MREO) current share price is $0.33. The gold spot price is $4,825.20 per troy ounce. Using the formula: MREO in gold = $0.33 × 31.1035 ÷ $4,825.20 = 0.0021 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of MREO when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding MREO shares over the measured period.

MREO in US Dollars
Gold in US Dollars
MREO in Gold (grams per share)

Real Wealth Growth Rate

MREO
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{MREO}_{\text{gold}}(t) = \frac{P_{\text{MREO}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{MREO}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{MREO}_{\text{gold}}^{(T)}}{\text{MREO}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{MREO}_\text{gold}^{(0)}$ = initial gold-price, $\text{MREO}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

TERN
TERN
Terns Pharmaceuticals, Inc.
$52.68
+0.13%
DAWN
DAWN
Day One Biopharmaceuticals, Inc.
$21.46
-0.14%
AMLX
AMLX
Amylyx Pharmaceuticals, Inc.
$16.92
+2.73%
INZY
INZY
Inozyme Pharma, Inc.
$4.00
+0.25%
ABOS
ABOS
Acumen Pharmaceuticals, Inc.
$2.68
+6.77%
PDSB
PDSB
PDS Biotechnology Corporation
$1.06
-2.75%
XFOR
XFOR
X4 Pharmaceuticals, Inc.
$4.20
+1.69%
ELEV
ELEV
Elevation Oncology, Inc.
$0.37
-2.12%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message